Dr. John H. Heinzerling
Claim this profileCarolinas Medical Center/Levine Cancer Institute
Studies Lung Cancer
Studies Small Cell Lung Cancer
5 reported clinical trials
19 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage II
Stage I
2Small Cell Lung Cancer
Stage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials John H. Heinzerling is currently running
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Radiation Therapy + Atezolizumab
for Small Cell Lung Cancer
This phase II/III trial compares the effect of adding radiation therapy to the usual maintenance therapy with atezolizumab versus atezolizumab alone in patients who have already received atezolizumab plus chemotherapy for the treatment of small cell lung cancer that has spread outside of the lung or to other parts of the body (extensive stage). Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving radiation therapy in addition to atezolizumab may extend the time without extensive small cell lung cancer growing or spreading compared to atezolizumab alone.
Recruiting1 award Phase 2 & 311 criteria
More about John H. Heinzerling
Clinical Trial Related8 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments John H. Heinzerling has experience with
- Docetaxel
- Gemcitabine
- Erlotinib Hydrochloride
- Local Consolidation Therapy
- Pemetrexed Disodium
- Atezolizumab
Breakdown of trials John H. Heinzerling has run
Lung Cancer
Small Cell Lung Cancer
Non-Small Cell Lung Cancer
Small Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John H. Heinzerling specialize in?
John H. Heinzerling focuses on Lung Cancer and Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage II.
Is John H. Heinzerling currently recruiting for clinical trials?
Yes, John H. Heinzerling is currently recruiting for 3 clinical trials in Charlotte North Carolina. If you're interested in participating, you should apply.
Are there any treatments that John H. Heinzerling has studied deeply?
Yes, John H. Heinzerling has studied treatments such as Docetaxel, Gemcitabine, Erlotinib Hydrochloride.
What is the best way to schedule an appointment with John H. Heinzerling?
Apply for one of the trials that John H. Heinzerling is conducting.
What is the office address of John H. Heinzerling?
The office of John H. Heinzerling is located at: Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina 28203 United States. This is the address for their practice at the Carolinas Medical Center/Levine Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.